Penumbra, Inc.
General ticker "PEN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $10.1B (TTM average)
Penumbra, Inc. follows the US Stock Market performance with the rate: 4.2%.
Estimated limits based on current volatility of 1.8%: low 286.89$, high 296.26$
Factors to consider:
- Total employees count: 3900 as of 2022
- US accounted for 75.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Geopolitical risks, IT system failures, Financing risks, Facility expansion challenges
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [163.55$, 270.64$]
- 2025-12-31 to 2026-12-31 estimated range: [166.00$, 275.84$]
Financial Metrics affecting the PEN estimates:
- Negative: with PPE of 83.7 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 0.78
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0.84 > -0.66
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.91
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 0.33 < Operating cash flow per share per price, % of 1.82
- Positive: Shareholder equity ratio, % of 75.07 > 63.39
Short-term PEN quotes
Long-term PEN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $847.13MM | $1,058.52MM | $1,194.62MM |
| Operating Expenses | $841.05MM | $984.97MM | $1,185.34MM |
| Operating Income | $6.08MM | $73.55MM | $9.28MM |
| Non-Operating Income | $-2.19MM | $6.10MM | $11.59MM |
| R&D Expense | $79.41MM | $102.64MM | $94.78MM |
| Income(Loss) | $3.89MM | $79.65MM | $20.87MM |
| Taxes | $5.89MM | $-11.30MM | $6.86MM |
| Profit(Loss)* | $-2.00MM | $90.95MM | $14.01MM |
| Stockholders Equity | $998.86MM | $1,178.94MM | $1,150.93MM |
| Inventory | $334.01MM | $388.02MM | $406.74MM |
| Assets | $1,370.89MM | $1,556.31MM | $1,533.18MM |
| Operating Cash Flow | $-55.66MM | $97.33MM | $168.48MM |
| Capital expenditure | $19.30MM | $15.21MM | $21.18MM |
| Investing Cash Flow | $54.79MM | $-16.08MM | $77.62MM |
| Financing Cash Flow | $11.62MM | $16.20MM | $-87.01MM |
| Earnings Per Share** | $-0.05 | $2.37 | $0.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.